APIMEDS PHARMACEUTICALS US, INC. (APUS) Deferred Tax Assets, Operating Loss Carryforwards, Domestic

APIMEDS PHARMACEUTICALS US, INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic

APIMEDS PHARMACEUTICALS US, INC. (APUS) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $9.47 million as of 2025-12-31, per its 10-K filed 2026-05-04.

Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-05-04

• 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $9.47M.